{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:51:04Z","timestamp":1769604664387,"version":"3.49.0"},"reference-count":22,"publisher":"Hindawi Limited","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3247,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01173.x","type":"journal-article","created":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T03:48:10Z","timestamp":1160624890000},"page":"1497-1501","source":"Crossref","is-referenced-by-count":45,"title":["Rufinamide: pharmacology, clinical trials, and role in clinical practice"],"prefix":"10.1155","volume":"60","author":[{"given":"A","family":"CHENG-HAKIMIAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. D.","family":"ANDERSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W.","family":"MILLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2006,10,11]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1212\/WNL.40.8.1163","article-title":"Seizure recurrence after a first unprovoked seizure; an extended follow-up","volume":"400","author":"Hauser","year":"1990","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/01.wnl.0000176055.45774.71","article-title":"Predicting long-term seizure outcome after resective epilepsy surgery; the multicenter study","volume":"65","author":"Spencer","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/01.WNL.0000163998.01543.CF","article-title":"Prognosis 30\u2003years after temporal lobectomy","volume":"64","author":"Kelley","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(98)00108-9","article-title":"Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)","volume":"34","author":"Bialer","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/(SICI)1099-081X(199805)19:4<259::AID-BDD98>3.0.CO;2-V","article-title":"The influence of food on the disposition of the antiepileptic drug rufinamide in healthy volunteers","volume":"19","author":"Cardot","year":"1998","journal-title":"Biopharm Drug Dispos"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1023\/A:1016275402723","article-title":"Intra- and inter-subject variabilities of CGP 33101 after replicate single oral doses of two 200\u2003mg tablets and 400\u2003mg suspension","volume":"12","author":"Cheung","year":"1995","journal-title":"Pharm Res"},{"issue":"Suppl. 5","key":"10.1111\/j.1742-1241.2006.01173.x-BIB8|cit8","first-page":"167","article-title":"Metabolism of the new anticonvulsant trial drug rufinamide (CGP33101) in healthy male volunteers","volume":"37","author":"Waldmeier","year":"1996","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"10.1111\/j.1742-1241.2006.01173.x-BIB9|cit9","first-page":"59","article-title":"A pharmacokinetic evaluation of rufinamide in elderly and younger subjects","volume":"39","author":"Chang","year":"1998","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"10.1111\/j.1742-1241.2006.01173.x-BIB10|cit10","first-page":"166","article-title":"Pharmacokinetics and safety of adjunctive rufinamide therapy in pediatric patients with epilepsy","volume":"39","author":"Sachdeo","year":"1998","journal-title":"Epilepsia"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-1211(00)00185-6","article-title":"Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy","volume":"43","author":"Palhagen","year":"2001","journal-title":"Epilepsy Res"},{"issue":"Suppl. 7","key":"10.1111\/j.1742-1241.2006.01173.x-BIB12|cit12","first-page":"255","article-title":"Efficacy and safety of rufinamide as adjunctive therapy in adult patients with therapy resistant partial onset seizures","volume":"41","author":"Vasquez","year":"2000","journal-title":"Epilepsia"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB13|cit13","volume-title":"Efficacy and Safety of Rufinamide Adjunctive Therapy in Patients with Lennox-Gastaut Syndrome (LGS): a Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Trial","author":"Glauser","year":"2005"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB14|cit14","volume-title":"Short and Long Term Safety of Rufinamide in Patients with Epilepsy","author":"Krauss","year":"2006"},{"issue":"Suppl. 7","key":"10.1111\/j.1742-1241.2006.01173.x-BIB15|cit15","first-page":"114","article-title":"Safety and Efficacy of open label rufinamide as adjunctive therapy in pediatric patients with partial seizures","volume":"40","author":"Litzinger","year":"1999","journal-title":"Epilepsia"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB16|cit16","volume-title":"The Effect of Rufinamide on the QT Interval in Healthy Subjects Treated During 18\u2003days with Multiple Ascending Doses: a Population PKPD Analysis","author":"Marchand","year":"2005"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1528-1167.2006.00589.x","article-title":"The effect of the new antiepileptic drug rufinamide on cognitive functions","volume":"47","author":"Aldenkamp","year":"2006","journal-title":"Epilepsia"},{"issue":"11 Suppl. 3","key":"10.1111\/j.1742-1241.2006.01173.x-BIB18|cit18","first-page":"17","article-title":"Clinical pharmacology of new antiepileptic drugs","volume":"55","author":"Willmore","year":"2000","journal-title":"Neurology"},{"issue":"Suppl. 6","key":"10.1111\/j.1742-1241.2006.01173.x-BIB19|cit19","first-page":"59","article-title":"Single-center, open-label, multiple dose pharmacokinetic trial investigating the effect of rufinamide administration on Ortho-Novum 1\/35 in healthy women","volume":"39","author":"Svendsen","year":"1998","journal-title":"Epilepsia"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut Syndrome","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut Syndrome: Topiramate YL Study Group","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2006.01173.x-BIB22|cit22","first-page":"29","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut Syndrome)","volume":"1328","author":"The Felbamate Study Group in Lennox-Gastaut Syndrome","year":"1993","journal-title":"N Engl J Med"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01173.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01173.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:04:58Z","timestamp":1643349898000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01173.x"}},"subtitle":["THE ROLE OF RUFINAMIDE"],"short-title":[],"issued":{"date-parts":[[2006,10,11]]},"references-count":22,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01173.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10,11]]}}}